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Pedigree: arrows indicate index case; slashes indicate deceased members; gray indicates structural heart alterations; plus/minus indicates carrier/noncarrier; and
question marks indicate no genetic analysis. Family 1: inﬂammatory inﬁltrates (hematoxylin-eosin, left 4, central 10 epicardium, right 10 myocardium). Family 2:
inﬂammatory inﬁltrates (left 20, hematoxylin-eosin, and right 20, CD45). Family 3: inﬂammatory inﬁltrates (hematoxylin-eosin labeling, left 10, right 20).
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Substrate for
Biventricular PacingIt is axiomatic that the presence of a substrate that
is amenable to a speciﬁc treatment, coupled with
effective delivery of that treatment, is likely to pro-
duce the most favorable clinical outcomes. In patients
with heart failure, left bundle branch block (LBBB)
and the associated abnormal electro-mechanical
activation represents the substrate for biventricular
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2915pacing (BivP). This LBBB substrate has been deﬁned
by (“strict”) electrocardiographic or echocardio-
graphic criteria.
Risumet al. (1) showed that echocardiographic LBBB
is independently associated with long-term survival
after BivP. The implicit assumptions are that: 1)
the echocardiographic criteria for LBBB is closely
aligned with the substrate that is amenable to
correction by BivP; 2) BivP was effective in reversing
the abnormal electro-mechanical activation; and
3) correction of the echocardiographic LBBB-
related electro-mechanical activation resulted in the
better outcomes in patients with echocardiographic
LBBB.
We have recently reported that baseline LBBB (by
the strict electrocardiographic criteria) and the
reversal of LBBB, as evidenced by reversal of elec-
trocardiographic activation pattern, was associated
with the most favorable clinical outcomes (2). Clinical
outcomes in patients with LBBB without correction
by BivP were comparable to patients with non-
LBBB, which supports electrocardiographic LBBB as
a substrate for BivP.
In this regard, it is not clear if the clinical
outcomes observed by Risum et al. (1) are due to
correction of the echocardiographic LBBB-related
electro-mechanical contraction abnormality by BivP,
or even worsening of the contraction pattern in
patients without echocardiographic LBBB. The clinical
outcomes in patients with/without echocardiographic
LBBB and with/without correction by BivP should
be examined to demonstrate the relevance of
echocardiographic LBBB as a (or perhaps the)
substrate for BivP.*Hoong Sern Lim, MD
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Rhythm 2015;11:2247–55.REPLY: Echocardiographic Substrate for
Biventricular PacingWe appreciate Dr. Lim’s interest in our recent paper (1).
We demonstrated that patients without typical left
bundle branch block (LBBB) contraction by echocar-
diography, despite LBBB by electrocardiography,
have more than a 3-fold risk of death, heart transplant,
or left ventricular assist device within 4 years after
cardiac resynchronization therapy (CRT) implantation
(1). We agree that it is an important point that CRT
results in correction of the echocardiographic LBBB-
related contraction abnormality but in some cases
may cause worsening of the contraction pattern.
Indeed, recent studies suggest that CRT can be
harmful (2). Our previous work supports that a
typical contraction pattern can be reversed by CRT
whereas other patterns cannot, in which case a poor
outcome can be expected (3). Furthermore, it is
evident that LBBB contraction and activation do not
always agree. Despite the presence of complete
LBBB-activation, scarring of the ventricle may
abolish typical LBBB contraction in which case there
is no mechanical substrate for CRT (4) and the
patient is unlikely to respond favorably (5). This is
part of the explanation why it can be important to
address mechanical contraction in selection of CRT
candidates and why we found identiﬁcation of
typical LBBB contraction by echocardiography to be
superior to strict LBBB criteria by ECG (1). We
welcome any publications that offer logical
descriptors of pathophysiology that relate electrical
to mechanical events in the heart. Such studies are
important to understand why some patients respond
to CRT and others do not.*Niels Risum, MD, PhD
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